Finzati - Logo
TAOX logo

TAO Synergies Inc.

TAOX • Biotechnology
$0.00
— 0.00 (0.00%)
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$26.00M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 13.99Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 13, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:33 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$26.00M
52W Range3.18 - 10.00
Beta1.47
Gross Margin100.00%
Oper. Margin-30.25%
Profit Margin-96.09%
Debt/Eq0.00
Current Ratio13.99
Quick Ratio13.99
Volume103.30K

Investment DNA

How strong this company looks for long-term investors

40
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
58/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 13.99Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 7/2/2025
Industry: Biotechnology
P/B i: 0.55
Debt / Equity i: 0.00
Operating Margin: -3025.19%
Net Margin: -9609.23%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: 0.00
Current Ratio: 13.99
Quick Ratio: 13.99
Status: Good

Insider Transactions

Recent executive and insider activity

Ephron Robert
Transaction: 05/18/2026
BUY
Change
+10,000
Price
$4.80
Filing
05/19/2026
Type
BUY
WEINSTEIN ROBERT
Transaction: 05/18/2026
BUY
Change
+30,000
Price
$4.80
Filing
05/19/2026
Type
BUY
Singer William S.
Transaction: 05/18/2026
BUY
Change
+35,000
Price
$4.80
Filing
05/19/2026
Type
BUY